China Accelerates Its Steps in the Brain–Computer Interface Industry

China Accelerates Its Steps in the Brain–Computer Interface Industry… in Direct Competition with Neuralink

While the American company Neuralink promotes itself as one of the foremost pioneers in brain–computer interface (BCI) technologies, China is moving at a remarkable pace to transform research in this field into large-scale commercial applications, backed by clear government policies, substantial funding, and an acceleration of clinical trials.

From the Lab to the Market

Founders of Chinese startups specializing in brain chips and neural interfaces indicate that the sector has entered a phase of actual expansion.
The matter is no longer confined to academic research — some Chinese provinces have begun setting medical pricing for brain–computer interface services, as a preliminary step toward incorporating them into the national health insurance system, paving the way for wider adoption of the technology.

In a strategic move, China's Ministry of Industry, in collaboration with several government bodies, launched a national roadmap targeting technological breakthroughs by 2027, with the goal of building an integrated industrial supply chain by 2030 and establishing companies capable of competing globally.

Beijing also announced a brain science fund worth 11.6 billion yuan (approximately 165 million dollars) to support companies at various stages, from research and development through to commercial marketing.

Four Factors Driving China's Growth

According to sector experts, China's progress in this field rests on four fundamental pillars:

Strong political support and institutional coordination, encompassing the unification of technical standards and medical payment mechanisms.

A broad clinical base and lower research costs, which accelerate trials and approvals — in contrast to the United States, where separate approvals from private insurance bodies are required.

An advanced industrial infrastructure in semiconductors, AI, and medical devices, which accelerates the development of prototypes.

Intensive strategic investments from government funds and private capital.

Advanced Clinical Trials and Global Competition

Chinese researchers achieved a notable milestone by completing a trial of a fully implanted, wireless brain–computer interface — making it the second in the world after Neuralink's trial.
This technology enabled a paralyzed patient to control electronic devices without the need for external equipment.

Estimates indicate that the Chinese market for brain–computer interfaces will exceed 530 million dollars in 2025, with projections of reaching more than 120 billion yuan by 2040.

Chinese companies are preparing to compete with prominent American players such as Synchron and Paradromics, at a time when the sector is witnessing major funding deals and moves toward stock exchange listings.

Two Technical Pathways: Surgical and Non-Surgical

The industry follows two main pathways:

1. Surgical Interfaces

These rely on implanting electrodes directly inside the brain, providing very high precision in reading neural signals, but they carry surgical risks.

2. Non-Surgical Interfaces

These use devices such as EEG helmets to read neural activity through the skull. They are less precise but safer and easier to deploy widely.

A third approach is also emerging, using ultrasound to stimulate the brain without surgical intervention, with potential applications for treating chronic pain, strokes, and depression. Early trials have shown promising results.

Ethical and Regulatory Dimensions

It is expected that Chinese regulations will, over the coming years, align more closely with international standards such as IEC and ISO, with tighter oversight of surgical devices and user data, and reinforced requirements for informed consent and ethical reviews.

The conversation is no longer limited to treating diseases — it extends to deeper questions concerning the privacy of neural data and the boundaries of human–machine integration.

From Treatment to Enhancing Human Capabilities

In the near term, these technologies focus on medical applications, such as assisting patients with paralysis or neurological disorders.
But the longer-term vision is directed toward enhancing human capabilities through deeper integration between neuroscience and AI.

Amid ambitions to merge "biological intelligence" with "silicon intelligence," China is entering a strategic race that may reshape the relationship between humans and technology over the coming decades.

For everything new, you should follow Arabic websites and specialized blogs, alongside what is offered by Egyptian stores and Kuwait stores and vitamin stores and foreign websites, while relying on Mashhor website for social media services.